Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 1,4-Dioxane | HCID 31275 | — |
| Reactant | Potassium Phosphate, Tribasic | HCID 62657 | — |
| Reactant | HCID 58497179 | HCID 58497179 | — |
| Reactant | HCID 178430905 | HCID 178430905 | — |
| Catalyst | HCID 178418397 | HCID 178418397 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Product | HCID 44554596 | HCID 44554596 | — |
Reaction Steps
A mixture of Example 133 compound (60 mg, 0.119 mmol), methylpyrazole boronic acid (29.7 mg, 0.143 mmol), Pd(PPh3)4 (13.7 mg, 0.012 mmol), K3PO4 (50.5 mg, 0.238 mmol, aq) in dioxane (2 ml) was vacuumed and purged to N2 for 3 times, then reaction mixture was heated at 110° C. for 3 hrs. Reaction mixture was diluted with EtOAc, washed with brine dried and concentrated. Separated by prep TLC (hex:EtOAc:CH3OH=6:5:1) to give 4-{5-[(4-chlorophenyl)sulfanyl]-1-methyl-4-[4-(methylsulfonyl)phenyl]-1H-imidazol-2-yl}-1-methyl-1H-pyrazole (25 mg) 1H NMR (500 MHz), [(CDCl3]: 8.35 (m, 1H), 7.95 (m, 3H), 7.25 (m, 3H), 7.01 (m, 2H), 4.10 (s, 3H), 3.78 (s, 3H), 3.10 (s, 3H). LCMS: [M+1]+=459.0. Human FAAH lysate assay: IC50=13.9 nM.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08455528B2 |
|---|
| Source dataset | uspto-grants-2013_06 |
|---|
| ORD ID | ord-27304e4989dc405994e16b2524b2a737 |
|---|
| Source note | uspto-grants-2013_06 |
|---|